Table 2. Clinical characteristics of the leprosy patients enrolled in this study.
| Leprosy | Leprosy classification (n, %) | n | Gender ratio | Mean age | Bacterial index (BI) | ||
| WHO* | RJ** | (n, %) | (M/F) | Year (range) | Skin-slit smear | Pathology | |
| MB | LL | 4 | 3/1 | 40.0 (24–59) | 1–3.5+ | 5.5–6+ | |
| BL | 32 | 20/12 | 42.3 (21–91) | 1–5+ | 2.2–5+ | ||
| BB | 2 | 2/0 | 43.0 (34–52) | 4+ | 2.6+ | ||
| PB | BT | 14 | 7/7 | 46.0 (17–84) | 0–1.2+ | 0–3.5+ | |
| TT | 9 | 7/2 | 44.9 (29–62) | 0 | 0 | ||
| Post-MDT | LL | 3 | 3/0 | 60.3 (54–68) | - | - | |
| BL | 8 | 5/3 | 65.8 (48–80) | - | - | ||
| BB | 0 | - | - | - | - | ||
| BT | 8 | 6/2 | 62.9 (52–80) | - | - | ||
| TT | 3 | 3/0 | 62.3 (42–78) | - | - | ||
| Controls | HHC | 119 | 57/62 | 33.7 (2–87) | - | - | |
| TB - |
11 | 8/3 | 44.5 (28–77) | - | - | ||
| EC | 31 | 18/13 | 39.2 (32–48) | - | - | ||
n: number of patients, with percentages in parentheses.
*WHO: Operational classification proposed by the World Health Organization.
** RJ: Ridley-Jopling classification.